[
1. BOLAKI M, ANTONIOU KM. Combined Pulmonary Fibrosis and Emphysema. Semin Respir Crit Care Med 2020; 41(2): 17–183.10.1055/s-0040-1708058
]Search in Google Scholar
[
2. HAGE R, GAUTSCHI F, STEINACK C, SCHUURMANS MM. Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management. Int J Chron Obstruct Pulmon Dis 2021; 16: 167–77.10.2147/COPD.S286360
]Search in Google Scholar
[
3. KOO BS, PARK KY, LEE HJ, KIM HJ, AHN HS, YIM SY, et al. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther 2021; 23(1): 100.10.1186/s13075-021-02494-y
]Search in Google Scholar
[
4. COTTIN V, NUNES H, MOUTHON L, GAMONDES D, LAZOR R, HACHULLA E, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63(1): 295–304.10.1002/art.30077
]Search in Google Scholar
[
5. HAMAGUCHI Y, FUJIMOTO M, MATSUSHITA T, KAJI K, KOMURA K, HASEGAWA M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-t-RNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 2013; 8: e60442.10.1371/journal.pone.0060442
]Search in Google Scholar
[
6. KOREEDA Y, HIGASHIMOTO I, YAMAMOTO M, TAKAHASHI M, KAJI K, FUJIMOTO M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010; 49(5): 361–9.10.2169/internalmedicine.49.2889
]Search in Google Scholar
[
7. DAIDO W, YAMASAKI M, MORIO Y, FUNAISHI K, ISHIYAMA S, DEGUCHI N, et al. A rare combination of dermatomyositis, IP, and lung cancer in a patient treated with immunosuppressive therapy and chemotherapy. Intern Med. 2018; 57(6): 849–53.10.2169/internalmedicine.9642-17
]Search in Google Scholar
[
8. TARGOFF IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20(4): 857–80.10.1016/S0889-857X(21)00070-3
]Search in Google Scholar
[
9. MARGUERIE C, BUNN CC, BEYNON HL, BERNSTEIN RM, HUGHES JM, SO AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77(282): 1019–38.10.1093/qjmed/77.1.10192267280
]Search in Google Scholar
[
10. LOVE LA, LEFF RL, FRASER DD, TARGOFF IN, DALAKAS M, PLOTZ PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70(6): 360–74.10.1097/00005792-199111000-000021659647
]Search in Google Scholar
[
11. HIRAKATA M, NAGAI S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12(6): 501–8.10.1097/00002281-200011000-0000511092199
]Search in Google Scholar
[
12. YOKOI E, HARUTA Y, WADA Y, ITO H, MACHIDA K, MATSUO M. Three cases of interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies complicated by gynecological cancer. Nihon Kokyuuki Gakkai Zassi 2018: 7(4): 229–32 (in Japanese).
]Search in Google Scholar
[
13. SHIKANO K, KANEKO K, KABURAKI K, ISOBE K, KAWABE K, HOMMA S, et al. Nivolumab-induced anti-aminoacyltRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma. Scand J Rheumatol 2020; 49(1): 82–83.10.1080/03009742.2019.159630931135242
]Search in Google Scholar
[
14. FUJITA Y, HIRANO S, YONESHIM Y, IZUMI S, TAKEDA Y, SUGIYAMA H, et al. A case of acute exacerbation of interstitial pneumonia complicated with dermatomyositis during treatment for lung cancer, and literature review. Nihon Kokyuki Gakkai Zasshi 2011; 49(2): 108–15 (in Japanese).
]Search in Google Scholar
